Evaluation of the effectiveness of combination therapy using SSRIs and bioacoustic correction in patients with panic and generalized anxiety disorders: focus on somatovegetative disorders

Evaluation of the effectiveness of combination therapy using SSRIs and bioacoustic correction in patients with panic and generalized anxiety disorders: focus on somatovegetative disorders

 

Authors

 

T.A. Karavaeva

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

A.V. Vasilieva

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

D.A. Starunskaya

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

D.S. Radionov

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

A.E. Andrianova

Federal State Budgetary Institution “V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation, St. Petersburg, Russian Federation

 

https://doi.org/10.26617/1810-3111-2025-2(127)-70-83

 

Journal: Siberian Herald of Psychiatry and Addiction Psychiatry. 2025; 2 (127):  70-83.

 

Abstract

Materials. The study was conducted at the Department of the Treatment of Borderline Mental Disorders and Psychotherapy of the Bekhterev National Medical Research Center for Psychiatry and Neurology from February 2024 to February 2025. Objective: comparative assessment of symptom dynamics in patients with panic disorder (PD) and generalized anxiety disorder (GAD) receiving SSRI pharmacotherapy and its combination with bioacoustic correction (BAC). The clinical sample included patients (n=60) with PD and GAD, divided into two groups: the main group (n=30) ‒ receiving medications, 15 BAC sessions; control group (n=30) ‒ receiving only medications (sertraline, paroxetine, fluvoxamine, fluoxetine). Research Question: to evaluate the effect of SSRI pharmacotherapy and BAC on the severity of anxiety-depressive manifestations, asthenovegetative and sleep disorders in patients with PD and GAD with subclinical depressive symptoms. For the purpose of psychodiagnostic assessment, specialist tests, scales and questionnaires were used: HARS (anxiety), PHQ-9 (depression), the Wein questionnaire (vegetative disorders), ISI (insomnia) and CGI (clinical state). Results. In the main group, the combination therapy demonstrated a significant decrease in anxiety (HARS: from 26.03 to 14.16 points) and depression (PHQ-9: from 14.37 to 4.18), improvement in autonomic parameters (statistically significant decrease in autonomic disorders according to the Wein questionnaire by 34.5% ‒ from 35.20±12.66 to 23.06±12.52, p<0.001) and sleep quality (ISI: from 15.00 to 8.46). In the control group using only psychopharmacotherapy, a less pronounced improvement was found (HARS: from 22.33 to 17.63; PHQ-9: from 13.10 to 9.43). Intergroup analysis revealed statistically significant advantages of combination therapy, especially in the correction of emotional symptoms. BAC enhances the effect of pharmacotherapy, effectively reducing anxiety-depressive and vegetative symptoms, as well as improving the sleep. Method is safe and recommended to patients with resistance to standard treatment.

 

Keywords: panic disorder, generalized anxiety disorder, depression, comorbid disorders, somatovegetative disorders, remission stabilization, antidepressant therapy, bioacoustic correction.

 

Article (pdf)

 

Contacts

This email address is being protected from spambots. You need JavaScript enabled to view it.

 

Materials  

For citation: Karavaeva T.A., Vasilieva A.V., Starunskaya D.A., Radionov D.S., Andrianova A.E. Evaluation of the effectiveness of combination therapy using SSRIs and bioacoustic correction in patients with panic and generalized anxiety disorders: focus on somatovegetative disorder. Sibirskii Vestnik Psikhiatrii i Narkologii.2025; 2 (127): 70-83. https://doi.org/10.26617/1810-3111-2025-2(127)-70-83

 

 

REFERENCES

 

  1. Psychotherapy: National Handbook. Moscow: GEOTAR-Media, 2023:992 (in Russian).
  2. Karavaeva TA, Vasilieva AV, Poltorak SV. Principles and algorithms of neurotic level anxiety disorders (anxiety-phobic, panic and generalized anxiety disorders) psychotherapy. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2016;(4):42-51 (in Russian).
  3. Generalized anxiety disorder: electronic publication / Vasilieva AV, Zinchenko YuP, Isaeva ER. et al. Moscow: Ministry of Health of Russia, 2024:121 (in Russian).
  4. Panic disorder: Adults / AV Vasilieva, YuP Zinchenko, ER Isaeva et al. Moscow: Ministry of Health of the Russian Federation, 2024:140 (in Russian).
  5. Yang X, Fang Y, Chen H, Zhang T, Yin X, Man J, Yang L, Lu M. Global, regional and national burden of anxiety disorders from 1990 to 2019: results from the Global Burden of Disease Study 2019. Epidemiol Psychiatr Sci. 2021 May 6;30:e36. https://doi.org/10.1017/S2045796021000275. PMID: 33955350; PMCID: PMC8157816.
  6. Sacco R, Camilleri N, Umla-Runge K. The prevalence of anxiety disorders among young people in Europe: A systematic review and meta-analysis. Eur Psychiatry. 2021 Aug 13;64(Suppl 1):S617. https://doi.org/10.1192/j.eurpsy.2021.1640. PMCID: PMC9480391.
  7. Jeanne M, Carson F, Toledo F. Neuroanatomical correlates of anxiety disorders and their implications in manifestations of cognitive and behavioral symptoms. Psych. 2024;6(1):34-44. https://doi.org/10.3390/psych6010003.
  8. Kahlon SK, Ali Z, Pritchard E, Saravia S, Baten C, Klassen AM, Shepherd JH, Zamora G, Jordan J, Duran M, Santos SL, Hedges DW, Hamilton JP, Sacchet MD, Miller CH. Neural abnormalities associated with generalized anxiety disorder: a meta-analysis of functional magnetic resonance imaging activation studies. Eur Psychiatry. 2023 Jul 19;66(Suppl 1):S452. https://doi.org/10.1192/j.eurpsy.2023.971. PMCID: PMC10434379.
  9. Chen A, Metzger E, Lee S, Osser D. A Proposed algorithm for the pharmacological treatment of generalized anxiety disorder in the older patient. J Geriatr Psychiatry Neurol. 2025 May;38(3):155-171. https://doi.org/10.1177/08919887241289533. Epub 2024 Oct 1. PMID: 39352792.
  10. Katzman MA. Current considerations in the treatment of generalized anxiety disorder. CNS Drugs. 2009;23(2):103-20. https://doi.org/10.2165/00023210-200923020-00002. PMID: 19173371.
  11. Quagliato LA, Freire RC, Nardi AE. Risks and benefits of medications for panic disorder: a comparison of SSRIs and benzodiazepines. Expert Opin Drug Saf. 2018 Mar;17(3):315-324. https://doi.org/10.1080/14740338.2018.1429403. Epub 2018 Jan 22. PMID: 29357714.
  12. Bandelow B, Allgulander C, Baldwin DS et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders ‒ Version 3. Part I: Anxiety disorders. World J Biol Psychiatry. 2023 Feb;24(2):79-117. https://doi.org/10.1080/15622975.2022.2086295. Epub 2022 Jul 28. PMID: 35900161.
  13. Karavaeva TA, Vasilieva AV, Radionov DS, Starunskaya DA, Andrianova AE. Clinical and etiopathogenetic aspects of depressive and anxiety disorders’ comorbidity: towards the problem of achieving stable remission. V.M. Bekhterev Review of Psychiatry and Medical Psychology. 2024;58(4-1):23-33 https://doi.org/10.31363/2313-7053-2024-975(in Russian).
  14. Hou Y, Zhang S, Li N, Huang Z, Wang L, Wang Y. Neurofeedback training improves anxiety trait and depressive symptom in GAD. Brain Behav. 2021 Mar;11(3):e02024. https://doi.org/10.1002/brb3.2024. Epub 2021 Jan 27. PMID: 33503332; PMCID: PMC7994677.
  15. Baevsky RM, Berseneva AP. Assessment of the body's adaptive capacity and the risk of developing diseases. Moscow: Meditsina,1997:27 (in Russian).
  16. Kotova ОV, Akarachkova ES, Belyaev AA. Psychovegetative syndrome: challenges in diagnosis and effective treatment. Medical Council. 2018(21):50-55. https://doi.org/10.21518/2079-701X-2018-21-50-55(in Russian.
  17. Vegetative disorders: Clinical picture, diagnosis, treatment / AM Wein, ed. Moscow: Medical Information Agency, 2003:749 (in Russian).
  18. Orlova I, Orlov F, Golenkov A. Psychovegetative syndromes in neurological patients. The Doctor. 2019;30(12):18-21 (in Russian).
  19. Akarachkova ES. On the issue of diagnosis and treatment of psychovegetative disorders in general somatic practice. Attending Physician. 2010;10:60 (in Russian).
  20. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res. 2003;12(1):34-43. https://doi.org/10.1002/mpr.140. PMID: 12830308; PMCID: PMC6878426.
  21. Aiarzaguena JM, Grandes G, Salazar A, Gaminde I, Sánchez A. The diagnostic challenges presented by patients with medically unexplained symptoms in general practice. Scand J Prim Health Care. 2008;26(2):99-105. https://doi.org/10.1080/02813430802048662. PMID: 18570008; PMCID: PMC3406656.
  22. Liao SC, Ma HM, Lin YL, Huang WL. Functioning and quality of life in patients with somatic symptom disorder: The association with comorbid depression. Compr Psychiatry. 2019 Apr;90:88-94. https://doi.org/10.1016/j.comppsych.2019.02.004. Epub 2019 Feb 16. PMID: 30818088.
  23. Chew-Graham CA, Heyland S, Kingstone T, Shepherd T, Buszewicz M, Burroughs H, Sumathipala A. Medically unexplained symptoms: continuing challenges for primary care. Br J Gen Pract. 2017 Mar;67(656):106-107. doi: 10.3399/bjgp17X689473. Erratum in: Br J Gen Pract. 2019 Jul;69(684):333. https://doi.org/10.3399/bjgp19X704285. PMID: 28232334; PMCID: PMC5325626.
  24. Li M, Wang R, Zhao M, Zhai J, Liu B, Yu D, Yuan K. Abnormalities of thalamus volume and resting state functional connectivity in primary insomnia patients. Brain Imaging Behav. 2019 Oct;13(5):1193-1201. https://doi.org/10.1007/s11682-018-9932-y. PMID: 30091019.
  25. Killgore W, Henderson-Arredondo K, Jankowski S, PatelS,HildebrandL, HuskeyA,  NegelspachD,  GrandnerMA,  Reich-FuehrerM, FrancaG,  WellmanC, DaileyN. Winding down for the Night: Changes in thalamocortical connectivity before bed are associated with deeper sleep. Sleep. 2024;47(Suppl 1):A289-A290. https://doi.org/10.1093/sleep/zsae067.0677.
  26. KlimanovaSG, RadionovDS, ShovaNI, KotsyubinskayaYuV, YaryginaYuV, BerezinaAA, SivakovaNA, StarunskayaDA, YakuninaON, AndrianovaAE, ZakharovDV, RybakovaKV, KaravaevaTA, VasilievaAV, MikhailovVA, KrupitskyEM. The use of melatoninergic antidepressants for stabilization of remission in depression comorbid with alcohol abuse, anxiety or neuropsychiatric disorders: a systematic review. Consortium Psychiatricum. 2024;5(4):40-62. https://doi.org/10.17816/CP15560 (in Russian).
  27. Hoge EA, Marques L, Wechsler RS, Lasky AK, Delong HR, Jacoby RJ, Worthington JJ, Pollack MH, Simon NM. The role of anxiety sensitivity in sleep disturbance in panic disorder. J Anxiety Disord. 2011 May;25(4):536-8. https://doi.org/10.1016/j.janxdis.2010.12.008. Epub 2011 Jan 13. PMID: 21277737.
  28. NemchinTA. States of neuropsychiatric tension. Leningrad: Publishing House of Leningrad State University, 1983:166 (in Russian).
  29. Konstantinov KV, Leonova MK, Miroshnikov DB, KlimenkoVM. Characteristics of the perception of acoustic images of intrinsic electrical activity by the brain. Neurosci Behav Physi. 2016;46:57-63. https://doi.org/10.1007/s11055-015-0198-1.
  30. Konstantinov KV, Leonova MK, Klimenko VM. The dependence of the dynamics in the band of theta on the time delay and level of consistency in the presentation of the acoustic image own EEG. Russian Journal of Physiology. 2015;101(4):481-491 (in Russian).
  31. Bandelow B, Allgulander C, Baldwin DS et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for treatment of anxiety, obsessive-compulsive and posttraumatic stress disorders ‒ Version 3. Part I: Anxiety disorders. World J Biol Psychiatry. 2023 Feb;24(2):79-117. https://doi.org/10.1080/15622975.2022.2086295. Epub 2022 Jul 28. PMID: 35900161.
  32. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995 Apr;39(3):315-25. https://doi.org/10.1016/0022-3999(94)00125-o. PMID: 7636775.
  33. Bastien CH, Vallières A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. https://doi.org/10.1016/s1389-9457(00)00065-4. PMID: 11438246.
  34. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep. 1991 Dec;14(6):540-5. https://doi.org/10.1093/sleep/14.6.540. PMID: 1798888.
  35. Kanzler SA, Cidral-Filho FJ, Kuerten B, Prediger RD. Effects of acoustic neurostimulation in healthy adults on symptoms of depression, anxiety, stress and sleep quality: a randomized clinical study. Explor Neuroprot Ther. 2023;3:481-496. https://doi.org/10.37349/ent.2023.0006.
  36. Al-Shargie F, Katmah R, Tariq U, Babiloni F, Al-Mughairbi F, Al-Nashash H. Stress management using fNIRS and binaural beats stimulation. Biomed Opt Express. 2022 May 24;13(6):3552-3575. https://doi.org/10.1364/BOE.455097. PMID: 35781942; PMCID: PMC9208616.
  37. Arns M, Kenemans JL. Neurofeedback in ADHD and insomnia: vigilance stabilization through sleep spindles and circadian networks. Neurosci Biobehav Rev. 2014 Jul; 44:183-94. https://doi.org/10.1016/j.neubiorev.2012.10.006.Epub 2012 Oct 23. PMID: 23099283.
  38. Douch M, Soubrier M, Pinaud C, et al. Development of an auditory neurofeedback during sleep onset process. Sleep. 2020;43(Suppl 1):A462-A463. https://doi.org/10.1093/sleep/zsaa056.1204.
  39. Sugimoto K, Ohmomo H, Shutoh F, Nogami H, Hisano S. Presentation of noise during acute restraint stress attenuates expression of immediate early genes and arginine vasopressin in the hypothalamic paraventricular nucleus but not corticosterone secretion in rats. Neurosci Res. 2015 Jul;96:20-9. https://doi.org/10.1016/j.neures.2014.11.010. Epub 2014 Dec 8. PMID: 25496933.
  40. Keller-Wood M. Hypothalamic-pituitary ‒ adrenal axis-feedback control. Compr Physiol. 2015 Jul 1;5(3):1161-82. https://doi.org/10.1002/cphy.c140065. PMID: 26140713.
  41. Ruggiero RN, Rossignoli MT, Marques DB, de Sousa BM, Romcy-Pereira RN, Lopes-Aguiar C, Leite JP. Neuromodulation of hippocampal-prefrontal cortical synaptic plasticity and functional connectivity: Implications for neuropsychiatric disorders. Front Cell Neurosci. 2021 Oct 11;15:732360. https://doi.org/10.3389/fncel.2021.732360. PMID: 34707481; PMCID: PMC8542677.
  42. Koganemaru S, Mikami Y, Maezawa H, Ikeda S, Ikoma K, Mima T. Neurofeedback Control of the human GABAergic system using non-invasive brain stimulation. Neuroscience. 2018 Jun 1;380:38-48. https://doi.org/10.1016/j.neuroscience.2018.03.051. Epub 2018 Apr 9. PMID: 29649513.
  43. Zich C, Johnstone N, Lührs M, Lisk S, Haller SP, Lipp A, Lau JY, Kadosh KC. Modulatory effects of dynamic fMRI-based neurofeedback on emotion regulation networks in adolescent females. Neuroimage. 2020 Oct 15;220:117053.https://doi.org/10.1016/j.neuroimage.2020.117053. Epub 2020 Jun 20. PMID: 32574803; PMCID: PMC7573536.
  44. Melnikov MY. The current evidence levels for biofeedback and neurofeedback interventions in treating depression: A narrative review. Neural Plast. 2021 Feb 4;2021:8878857. https://doi.org/10.1155/2021/8878857. PMID: 33613671; PMCID: PMC7878101.
  45. Konstantinov KV, Karpenko MN, Leonova MK. Dynamics of serotonin levels in sessions of listening to an acoustic image of their EEG. Neurocomputers: Development, Application.2014;7:32-36 (in Russian).
  46. Zotev V, Misaki M, Phillips R, Wong CK, Bodurka J. Real-time fMRI neurofeedback of the mediodorsal and anterior thalamus enhances correlation between thalamic BOLD activity and alpha EEG rhythm. Hum Brain Mapp. 2018 Feb;39(2):1024-1042. https://doi.org/10.1002/hbm.23902. Epub 2017 Nov 27. PMID: 29181883; PMCID: PMC6866453.
  47. Berboth S, Morawetz C. Amygdala-prefrontal connectivity during emotion regulation: A meta-analysis of psychophysiological interactions. Neuropsychologia. 2021 Mar 12;153:107767. https://doi.org/10.1016/j.neuropsychologia.2021.107767. Epub 2021 Jan 29. PMID: 33516732.
  48. Gergues MM, Han KJ, Choi HS, Brown B, Clausing KJ, Turner VS, Vainchtein ID, Molofsky AV, Kheirbek MA. Circuit and molecular architecture of a ventral hippocampal network. Nat Neurosci. 2020 Nov;23(11):1444-1452. doi: 10.1038/s41593-020-0705-8. Epub 2020 Sep 14. Erratum in: Nat Neurosci. 2021 Nov;24(11):1637. https://doi.org/10.1038/s41593-021-00941-2. PMID: 32929245; PMCID: PMC7606799.
  49. Moor LV, Rakhmazova LD. Clinical-dynamic characteristics and risk factors for panic disorders. Siberian Herald of Psychiatry and Addiction Psychiatry. 2019;3(104):14-20. https://doi.org/10.26617/1810-3111-2019-3(104)-14-20(in Russian).
  50. PogosovaIA, GolozubovaKN. The influence of complex therapy on the quality of life of patients with comorbid depressive and panic disorders. Siberian Herald of Psychiatry and Addiction Psychiatry. 2019; 1(102):18-27. https://doi.org/10.26617/1810-3111-2019-1(102)-18-27 (in Russian).